Novoprotein(SH:688137) Xin Lang Cai Jing·2026-01-05 01:40Core Viewpoint - The company, Suzhou Nearshore Protein Technology Co., Ltd., has shown a mixed financial performance with a significant increase in revenue but a notable decline in net profit for the period ending September 2025 [2]. Group 1: Financial Performance - As of November 10, 2025, Nearshore Protein reported a revenue of 112 million yuan, representing a year-on-year growth of 21.48% [2]. - The net profit attributable to the parent company was -28.86 million yuan, reflecting a year-on-year decrease of 58.06% [2]. - Cumulative cash dividends since the company's A-share listing amount to 70.18 million yuan [3]. Group 2: Shareholder and Market Activity - As of December 31, 2025, the number of shareholders decreased by 0.53% to 6,056, while the average circulating shares per person increased by 0.53% to 5,395 shares [2]. - On December 31, 2025, the financing balance for Nearshore Protein was 56.94 million yuan, accounting for 4.35% of the market capitalization, which is below the 10% percentile level over the past year [1]. - The top ten circulating shareholders include several funds, with notable changes in holdings, such as Huashang LeXiang Flexible Allocation Mixed A reducing its shares by 1,480 shares [3].